Please wait a minute...

中国生物工程杂志

China Biotechnology
China Biotechnology
China Biotechnology  2023, Vol. 43 Issue (5): 94-105    DOI: 10.13523/j.cb.2023005
    
Development Status and Countermeasures of Chongqing Biomedicine Industry——Accelerating the Construction of Biomedical High-tech Parks with the “Talent Chain” as the Driving Force
LONG Hui1,QI Zheng2,WU Hao3,4,*()
1 College of State Governance, Southwest University, Chongqing 400715, China
2 Capital Normal University Library, Beijing 100048,China
3 National Science Library, Chinese Academy of Sciences, Beijing 100190,China
4 Department of Information Resources Management, School of Economics and Management, University of Chinese Academy of Sciences, Beijing 100190,China
Download: HTML   PDF(629KB) HTML
Export: BibTeX | EndNote (RIS)      

Abstract  

Objective: To provide countermeasures and suggestions for the high-quality development of the biomedicine industry in Chongqing. Methods: Through literature, policy, news, and other network reports, the development trend and general characteristics of the biomedicine industry were summarized, and the general situation, achievements, advantages, deficiencies, and weaknesses of the development of the biomedicine industry in Chongqing were analyzed. This paper provides specific countermeasures and suggestions for such problems as talent shortage, the undustry lagging behind in transformation of innovative achievements, weak industrial competitiveness, the untapped advantage of traditional Chinese medicine resources, and a lack of leading enterprises. Results: The construction of the biomedicine industrial parks in Chongqing is focused on cultivating and supporting leading enterprises, building a multi-level investment support system, building industry-university-research community and improving community atmosphere, and strengthening multi-chain integration and development of industrial chain, capital chain, innovation chain, and talent chain.

Key words： Biomedicine      Industry      High-tech parks      Young scientific and technological talent      A sense of community     
Received: 05 January 2023      Published: 01 June 2023
ZTFLH:  Q819  
Service
E-mail this article
Add to my bookshelf
Add to citation manager
E-mail Alert
RSS
Articles by authors
LONG Hui
QI Zheng
WU Hao
Cite this article:

LONG Hui, QI Zheng, WU Hao. Development Status and Countermeasures of Chongqing Biomedicine Industry——Accelerating the Construction of Biomedical High-tech Parks with the “Talent Chain” as the Driving Force. China Biotechnology, 2023, 43(5): 94-105.

URL:

https://manu60.magtech.com.cn/biotech/10.13523/j.cb.2023005     OR     https://manu60.magtech.com.cn/biotech/Y2023/V43/I5/94

[1]   曹慧莉, 魏国旭. 2022年我国生物医药产业发展形势展望. 科技中国, 2022(1): 43-46.
[1]   Cao H L, Wei G X. Prospect of China’s biomedical industry development in 2022. Science and Technology in China, 2022(1): 43-46.
[2]   李婧, 宫庆彬, 张志强, 等. 成渝地区双城经济圈培育世界级生物医药产业集群研究. 中国西部, 2021(1): 12-20.
[2]   Li J, Gong Q B, Zhang Z Q, et al. Study on cultivating world-class biomedical industry cluster in Chengdu-Chongqing Shuangcheng economic circle. West China, 2021(1): 12-20.
[3]   廖敏, 李军锋, 向彦任, 等. 成渝城市群高新技术产业现状分析与协同发展政策研究. 科技与创新, 2020(19): 4-7, 11.
[3]   Liao M, Li J F, Xiang Y R, et al. Analysis on the status quo of high-tech industry in Chengyu city group and study on the policy of coordinated development. Science and Technology & Innovation, 2020(19):4-7,11.
[4]   金琳. 上海医药探索全产业链数字化转型. 上海国资, 2021(4):87-89.
[4]   Jin L. Shanghai Pharmaceutical explores digital transformation of the whole industrial chain. Capital Shanghai, 2021(4):87-89.
[5]   程芳. 中国生物医药产业乘势发展. 经济, 2021(12): 120-121.
[5]   Cheng F. Development of biomedical industry in China. Economy, 2021(12): 120-121.
[6]   Cui Y B, Yu L L. Application of the CRISPR/Cas9 gene editing technique to research on functional genomes of parasites. Parasitology International, 2016, 65(6): 641-644.
doi: 10.1016/j.parint.2016.08.011
[7]   Doudna J A, Charpentier E. The new frontier of genome engineering with CRISPR-Cas9. Science, 2014, 346(6213): e1258096.
[8]   袁博, 冯辰昀, 袁耀锋. 治疗COVID-19的小分子药物研究进展. 大学化学, 2022, 38:1-10.
[8]   Yuan B, Feng C Y, Yuan Y F. Research progress on small-molecule drugs for treating COVID-19. University Chemistry, 2022, 38:1-10.
[9]   马婕, 刘强. 无化学修饰的小分子药物靶蛋白鉴定技术及其应用进展. 生物工程学报, 2021, 37(4): 1131-1138.
[9]   Ma J, Liu Q. Identification techniques of small molecule drug target proteins without chemical modification and its applications: a review. Chinese Journal of Biotechnology, 2021, 37(4): 1131-1138.
[10]   Dejmek M, Konkolová E, Eyer L, et al. Non-nucleotide RNA-dependent RNA polymerase inhibitor that blocks SARS-CoV-2 replication. Viruses, 2021, 13(8): 1585.
doi: 10.3390/v13081585
[11]   Yu K H, Beam A L, Kohane I S. Artificial intelligence in healthcare. Nature Biomedical Engineering, 2018, 2(10): 719-731.
doi: 10.1038/s41551-018-0305-z
[12]   Ching T, Himmelstein D S, Beaulieu-Jones B K, et al. Opportunities and obstacles for deep learning in biology and medicine. Journal of the Royal Society, Interface, 2018, 15(141): 20170387.
doi: 10.1098/rsif.2017.0387
[13]   史光华, 张晓迪, 吕龙宝, 等. 实验动物机构标识系统的比较研究. 实验动物科学, 2017, 34(3):55-60, 65.
[13]   Shi G H, Zhang X D, Lv L B, et al. A comparative study on the identification system of laboratory animal. Laboratory Animal Science, 2017, 34(3):55-60, 65.
[14]   贺争鸣, 陈振文, 代解杰, 等. 实验动物品种增量建设与野生动物科学利用现状与建议. 中国科技资源导刊, 2021, 53(2):50-58.
[14]   He Z M, Chen Z W, Dai X J, et al. Status and suggestions for incremental construction of laboratory animal species and scientific utilization of wild animals. China Science & Technology Resources Review, 2021, 53(2):50-58.
[15]   苗明三. 实验动物和动物实验技术. 北京: 中国中医药出版社, 1997.
[15]   Miao M S. Experimental animals and animal experimental techniques. Beijing: China Press of Traditional Chinese Medicine Co. Ltd, 1997.
[16]   何莽. 中国康养产业发展报告(2017), 2017. 北京: 社会科学文献出版社, 2017.
[16]   He M. Annual report on health and wellness industry of China. Beijing: Social Sciences Literature Publishing House, 2017.
[17]   汪莉霞. 互联网时代下康养产业智慧化转型研究. 技术经济与管理研究, 2021(10): 109-112.
[17]   Wang L X. Research on the intelligent transformation of health care industry in the Internet era. Technoeconomics & Management Research, 2021(10): 109-112.
[18]   刘仲敏. 国内外生物医药产业发展现状. 河南科技, 2021, 40(24):155-158.
[18]   Liu Z M. Development status of biomedical industry at home and abroad. Journal of Henan Science and Technology, 2021, 40(24):155-158.
[19]   徐行. 重庆生物医药产业发展问题与对策:以重庆国际生物城为例. 新西部, 2021(5):72-74.
[19]   Xu X. Problems and countermeasures of bio-pharmaceutical industry development in Chongqing :Taking Chongqing International Bio-City as an example. New West, 2021(5):72-74.
[20]   郭绪忠. 重庆:力推生物医药产业上档次. 医药经济报, 2010(8).DOI:10.38275/n.cnki.nyyjj.2010.000945.
doi: 10.38275/n.cnki.nyyjj.2010.000945
[20]   Guo X Z. Chongqing: Push the bio-pharmaceutical industry to the top grade. Journal of Medical Economics, 2010 (8).DOI:10.38275/n.cnki.nyyjj.2010.000945.
doi: 10.38275/n.cnki.nyyjj.2010.000945
[21]   周凯. 重庆两江新区:“三链”融合打造生命健康产业高地. 经济参考报, 2022,(5).DOI:10.28419/n.cnki.njjck.2022.005184.
doi: 10.28419/n.cnki.njjck.2022.005184
[21]   Zhou K. Chongqing Liangjiang New Area: “Three chains” integration to create a highland of life and health industry. Economic Information Daily, 2022,(5).DOI:10.28419/n.cnki.njjck.2022.005184.
doi: 10.28419/n.cnki.njjck.2022.005184
[22]   温馨, 刁俊丽, 王世文. 科技金融服务生物医药产业高质量发展研究:基于苏州实践的分析. 农场经济管理, 2022(6): 46-49.
[22]   Wen X, Diao J L, Wang S W. Research on the high-quality development of technology and finance’s service biomedical industry: based on the analysis of Suzhou’s practice. Farm Economic Management, 2022(6): 46-49.
[23]   黄建伟, 谢兆海. 把握生物医药行业特点进一步发挥商业银行金融支持作用. 中国银行业, 2022(1): 75-78.
[23]   Huang J W, Xie Z H. Grasp the characteristics of biomedicine industry and further give play to the financial support role of commercial banks. China Banking, 2022(1):75-78.
[24]   吕钰涛. 中国生物医药产业发展的金融支持研究. 北京: 商务部国际贸易经济合作研究院, 2019.
[24]   Lv Y T. Research on financial support for the development of biomedical industry in China. Beijing: Chinese Academy of International Trade And Economic Cooperation, 2019.
[25]   陈琳, 施亚, 李艳, 等. 以提高创新实践能力为中心的人才培养体系构建:基于生物医药学科群建设的探索. 生物学杂志, 2020, 37(5): 127-129.
[25]   Chen L, Shi Y, Li Y, et al. The construction of a talent training system centered on improving the ability of innovation and practice: the exploration is based on biological and medical research and development. Journal of Microbiology, 2020, 37(5): 127-129.
[26]   洪璇, 张亚楠, 王英, 等. 基于产出导向的面向地方生物医药千亿产业链新工科人才培养探索. 中国医药导报, 2021, 18(28)75-78.
[26]   Hong X, Zhang Y N, Wang Y, et al. Exploration on the cultivation of new engineering talents facing the 100 billion industrial chain of local biomedicine according to the concept of outcomes-based education. China Medical Herald, 2021, 18(28)75-78.
[27]   俞晓轩, 范天豪, 徐立钧, 等. 基于产学研合作的国内外高校生物医药产业园模式发展探究1. 中国科技产业, 2022(1): 60-63.
[27]   Yu X X, Fan T H, Xu L J, et al. Research on the mode development of biomedical industrial park in universities at home and abroad based on industry-university-research cooperation 1. Science & Technology Industry of China, 2022(1): 60-63.
[28]   万里, 孙劲楠, 丁佐奇, 等. 产学研合作模式下长三角生物医药产业一体化协同创新发展研究:基于专利合作及基金项目合作. 中国药科大学学报, 2022, 53(6): 742-752.
[28]   Wan L, Sun J N, Ding Z Q, et al. Research on the development of bio-pharmaceutical industry integration and collaborative innovation in the Yangtze River Delta under the mode of Industry-University-Research cooperation. Journal of China Pharmaceutical University, 2022, 53(6): 742-752.
[29]   黄希庭. 社区心理学导论. 北京: 人民教育出版社, 2021.
[29]   Huang X T. Introduction to community psychology. Beijing: People’s Education Press, 2021.
[1] JI Yu-jie, QIN Han, XIANG Xue-rong. Application of Graphene Oxide in Bone Tissue Engineering[J]. China Biotechnology, 2023, 43(4): 71-78.
[2] Qian GAO,Hong JIANG,Yu-bao CHEN. In Vitro Diagnostics Industry in China: Current Status and Development Strategies[J]. China Biotechnology, 2022, 42(10): 105-111.
[3] WU Dong,XIAO Feng,YUAN Min,CHEN Yu-bao,ZHANG Hong-xiang. Transformation of Scientific and Technological Achievements in Biomedical Field in China from 2011 to 2020[J]. China Biotechnology, 2022, 42(1/2): 191-201.
[4] TAN Qing-li,LIN Dai-heng,LIU Jia-yuan,LIN Xing-chun. Study on the Benefits of Biomedical Industry in the Guangdong-Hong Kong-Macao Greater Bay Area Based on Grey Comprehensive Correlation Analysis[J]. China Biotechnology, 2021, 41(6): 89-97.
[5] WU Xiao-yan,CHEN Fang,DING Chen-jun,SUN Yu-tong. Analysis of Global Bioeconomy Status, Trends and Financing Prospects[J]. China Biotechnology, 2021, 41(10): 116-126.
[6] YIN Zheng-qing,BAI Jing-yu,LIN Xiao-feng. Competitiveness Analysis and Enlightenment of Biomedical Industry in USA[J]. China Biotechnology, 2020, 40(9): 87-94.
[7] BAI Jing-yu,LIN Xiao-feng,YIN Zheng-qing. Analysis of the Current Situation and Development Trend of Global Biotechnology Research Based on Bibliometrics[J]. China Biotechnology, 2020, 40(7): 100-109.
[8] WU Xiao-yan,CHEN Fang,DING Chen-jun,ZHENG Ying,SONG Qi. Analysis of the Global Biomanufacturing Industry Market and Financing Status[J]. China Biotechnology, 2020, 40(5): 117-124.
[9] HUANG Peng-fei,CHEN Yun,LU Jiao,MAO Kai-yun,YUAN Yin-chi. Development Situation and Suggestions of Biomedicine Patent-intensive Industry, Based on the Case Study of Shanghai[J]. China Biotechnology, 2020, 40(12): 108-116.
[10] XU Shu-yao,BAI Jing-yu,LIN Xiao-feng. Analysis of the Differences of China’s Bio-industry Based on the Perspective of Policy Tools[J]. China Biotechnology, 2020, 40(10): 96-103.
[11] Ying ZHENG,Zhi-qiang ZHANG. Development and Enlightenment of EU’s Bio-based R&I System[J]. China Biotechnology, 2018, 38(9): 99-105.
[12] Yan SU,Li XU,Li-wei WANG,Yue WANG,Ping XU. The Development Situation and Suggestions of mmune Cell Therapy Industry[J]. China Biotechnology, 2018, 38(5): 104-111.
[13] Fang CHEN,Yun-wei CHEN,Chen-jun DING,Ying ZHENG,Xiao-yan WU,Dan-dan LUO,Qiu-wei ZHAO,Bo YU. A Study on the Trends of Biotechnology Development in Countries along the Belt and Road[J]. China Biotechnology, 2018, 38(1): 1-14.
[14] ZHAO Shuang, LIU Liu, WU Lin-huan, MA Jun-cai. Research and Development Trend of the Technology on Corynebacterium glutamicum[J]. China Biotechnology, 2016, 36(9): 101-109.
[15] XIA Tai-shou, WANG Yuan-lei, TIAN Li-li. Reserch on Present Situation and Countermeasure of Jiangsu Biomedical Business Based on Patent[J]. China Biotechnology, 2016, 36(8): 123-130.
主管：中国科学院 　主办：中国科学院文献情报中心 　中国生物技术发展中心 　中国生物工程学会